Semaglutide is used for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an add-on to the ...

March 17 (Reuters) - Indian drugmakers Zydus Lifesciences and Lupin have signed a licensing and supply deal on Tuesday to ...

As part of the deal, Lupin will pay Zydus upfront licensing fees and milestone-based payments linked to predefined targets.